Joint and muscle discomfort are occasionally reported with GLP-1 medications, but they are not among the most common side effects
This aspect could reflect an altered action of ghrelin on its specific receptors implicated in feedback mechanisms.83 Regarding the role of CCK in inhibiting food intake, CCK-A receptor knockout rats are hyperphagic and obese.84 In animals, as expected, repeated preprandial administration of CCK reduces food intake but it also increases meal frequency, with no resulting effect on body weight.85 Circulating levels of PYY are not elevated in obese individuals
This is because its broader hormonal engagement may introduce confounding signaling activity
Overall, costs for the population of patients in this study are about 18,000 a year
[DOI] [PubMed] [Google Scholar] 8.Boger R.H., Bode-Boger S.M., Szuba A., Tsao P.S., Chan J.R., Tangphao O., Blaschke T.F., Cooke J.P
Do not start, stop, or change any GLP-1 program without talking to your healthcare provider, especially if you are pregnant, breastfeeding, taking other medications, or have a personal or family history of medullary thyroid carcinoma or MEN-2.